These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 31695803)

  • 21. Multifunctional nanoparticles for cancer immunotherapy.
    Saleh T; Shojaosadati SA
    Hum Vaccin Immunother; 2016 Jul; 12(7):1863-75. PubMed ID: 26901287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy.
    Han S; Huang K; Gu Z; Wu J
    Nanoscale; 2020 Jan; 12(2):413-436. PubMed ID: 31829394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumoural administration and tumour tissue targeting of cancer immunotherapies.
    Melero I; Castanon E; Alvarez M; Champiat S; Marabelle A
    Nat Rev Clin Oncol; 2021 Sep; 18(9):558-576. PubMed ID: 34006998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
    Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
    Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential applications of nanoparticles for tumor microenvironment remodeling to ameliorate cancer immunotherapy.
    Bai Y; Wang Y; Zhang X; Fu J; Xing X; Wang C; Gao L; Liu Y; Shi L
    Int J Pharm; 2019 Oct; 570():118636. PubMed ID: 31446027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of polymeric nanoparticles in immunotherapy.
    Craparo EF; Bondì ML
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):658-64. PubMed ID: 23095912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer Immunotherapy.
    Zhao H; Li Y; Wei D; Luo H
    J Immunol Res; 2018; 2018():3673295. PubMed ID: 30406152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors.
    Qian X; Shi Z; Qi H; Zhao M; Huang K; Han D; Zhou J; Liu C; Liu Y; Lu Y; Yuan X; Zhao J; Kang C
    Theranostics; 2019; 9(25):7616-7627. PubMed ID: 31695790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioactive Nanoparticles for Cancer Immunotherapy.
    Surendran SP; Moon MJ; Park R; Jeong YY
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics.
    Buss CG; Bhatia SN
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13428-13436. PubMed ID: 32493746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano-immunotherapy: Overcoming tumour immune evasion.
    Guevara ML; Persano F; Persano S
    Semin Cancer Biol; 2021 Feb; 69():238-248. PubMed ID: 31883449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity.
    Neri D
    Cancer Immunol Res; 2019 Mar; 7(3):348-354. PubMed ID: 30824549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanotechnology-based platforms to improve immune checkpoint blockade efficacy in cancer therapy.
    G Lahori D; Varamini P
    Future Oncol; 2021 Feb; 17(6):711-722. PubMed ID: 33136464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Particle-mediated delivery of cytokines for immunotherapy.
    Christian DA; Hunter CA
    Immunotherapy; 2012 Apr; 4(4):425-41. PubMed ID: 22512636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy.
    Hosseini M; Haji-Fatahaliha M; Jadidi-Niaragh F; Majidi J; Yousefi M
    Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1051-61. PubMed ID: 25612903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Advances in Stimuli-Responsive Platforms for Cancer Immunotherapy.
    Li L; Yang Z; Chen X
    Acc Chem Res; 2020 Oct; 53(10):2044-2054. PubMed ID: 32877161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy.
    Musetti S; Huang L
    ACS Nano; 2018 Dec; 12(12):11740-11755. PubMed ID: 30508378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLGA-nanoparticle mediated delivery of anti-OX40 monoclonal antibody enhances anti-tumor cytotoxic T cell responses.
    Chen M; Ouyang H; Zhou S; Li J; Ye Y
    Cell Immunol; 2014 Feb; 287(2):91-9. PubMed ID: 24487032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymeric Micelles in Cancer Immunotherapy.
    Wan Z; Zheng R; Moharil P; Liu Y; Chen J; Sun R; Song X; Ao Q
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33668746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving cancer immunotherapy through nanotechnology.
    Goldberg MS
    Nat Rev Cancer; 2019 Oct; 19(10):587-602. PubMed ID: 31492927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.